Search…

From treatment towards prevention! Roche (RHHBY.US) launches clinical trials for Alzheimer's Brainshuttle therapy.

15/07/2026

Zhtng Cijng APP learned that Roche (RHHBY.US) has announced a key clinical trial plan for its Alzheimer's disease antibody drug, hoping to prove that the drug can delay disease progression before symptoms appear. With competition intensifying, this pharmaceutical giant is racing against Eli Lilly (LLY.US) and Biogen to advance Alzheimer's disease treatment from "treatment" to "prevention" stage.

Latest

1 m ago

ASML, the world's largest computer chip manufacturing equipment supplier, announced Wednesday that its second quarter revenue and profits exceeded market expectations as demand from artificial intelligence chip makers offset uncertainties in sales to China. According to LSEG's median estimate data for the three months ending on June 30, ASML's revenue was 9.33 billion euros (approximately 10.9 billion US dollars), higher than analysts' expectations of 8.8 billion euros. Net profit was 2.92 billion euros, also higher than market expectations of 2.62 billion euros.

3 m ago

In the past 50 days, the Science and Technology Innovation Index has fallen by 5.03%. Among the component stocks, Bawei Storage fell by 14.85%, Muxi Stock fell by 13.84%, Shengmei Shanghai fell by 10.01%, and Tuojing Technology fell by 9.72%.

4 m ago

ASM International's US stocks rose more than 6% in night trading, now up over 3%. Prior to this, the company announced its Q2 performance with revenue of 9.326 billion euros, exceeding market expectations, and adjusted its 2026 outlook.

5 m ago

ASML: Intel is using high NA extreme ultraviolet lithography technology for manufacturing at its 18A process node.

6 m ago

ASM: Intel's foundry services use high numerical aperture extreme ultraviolet (EUV) technology on Intel's 18A process node.

See all latest